| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2802653501013 | 265350101 | MENOPUR PS.INJ.SOL (75IU FSH+75IU LH) BTx 5 VIALS +5 AMPS x 1 ML SOLVENT +5 AMPS x 1 ML SOLVENT | 75.64 | 79.35 | 100.93 |
| 05/2018 | 2802653502010 | 265350201 | MENOPUR PS.INJ.SOL 600 IU/VIAL BTx (1 VIAL + 1 PF. SYR.SOLV.) + 9 pads + 9 syringes SYR.SOLV.) + 9 pads + 9 syringes | 130.85 | 137.26 | 168.77 |
| 05/2018 | 2802653503017 | 265350301 | MENOPUR PS.INJ.SOL 1200IU/VIAL BTx (1 VIAL + 2 PF. SYR.SOLV.) +18 pads + 18 syringes SYR.SOLV.) +18 pads + 18 syringes | 261.75 | 265.68 | 315.41 |
For the treatment of female infertility
Being a combination drug, Menotropins bind to the Follicle stimulating hormone receptor (which results in ovulation in the absence of sufficient endogenous Luteinizing hormone)and It also binds to the LH receptor, thereby stimulating proper hormone release. The drug contains both FSH and LH,therefore, it induces ovarian follicular growth and development as well as gonadal steroid production in women who do not have ovarian failure.FSH is the primary driver of follicular recruitment and growth in early folliculogenesis, while LH is important for ovarian steroidogenesis and is involved in the physiological events leading to development of a competent pre-ovulatory follicle